NeuroSense Therapeutics | 424B5: Prospectus
Apr 12 16:35 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 12 16:33 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 09:02 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 9 08:35 ET
NeuroSense Therapeutics | EFFECT: Others
Apr 9 06:04 ET
NeuroSense Therapeutics | EFFECT: Others
Apr 9 06:04 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 5 09:33 ET
NeuroSense Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 4 17:12 ET
NeuroSense Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 4 16:42 ET
NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report
Apr 4 16:37 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 22 08:31 ET
NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(6.9%)
Feb 13 13:25 ET
NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(19.98%)
Feb 13 10:19 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 7 09:40 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 9 00:00 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 9 00:00 ET
NeuroSense Therapeutics | 424B3: Prospectus
Dec 27, 2023 00:00 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 27, 2023 00:00 ET
NeuroSense Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 21, 2023 08:45 ET
NeuroSense Therapeutics | 424B3: Prospectus
Dec 14, 2023 16:30 ET
No Data
No Data